# FDA Inspection 1224921 - Octapharma Plasma Inc - December 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e1b577e6-66dd-4321-ae14-41bb200d6f5e
Source feed: FDA_Inspections

> FDA Inspection 1224921 for Octapharma Plasma Inc on December 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224921
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-12-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/bea0c335-e930-453c-a194-36ec8d101923

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d